Harnessing Molecular Insights for Enhanced Drug Sensitivity and Immunotherapy in Cancer

15k
Total downloads
59k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 11 Jun 2025

Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed

Meng Li-Fei
Si-Meng Ren
Jun Wang
Wei-Jun Zhao
Jian Chen
Wen-Tao Hu

doi 10.3389/fimmu.2025.1601982

162 views

ORIGINAL RESEARCH

Accepted on 10 Jun 2025

Bioinformatics-based analysis of nicotinamide adenine dinucleotide metabolism genes to predict immune status and prognosis for head and neck squamous cell carcinoma patients

Zhenjie Guan
Xinyu Gu
Lian Zheng

doi 10.3389/fimmu.2025.1609175

ORIGINAL RESEARCH

Published on 10 Jun 2025

Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer

Chuanzhi Chen
Jiahui Qi
Weichao Lin
Chunlan Fu
Xin Jin

doi 10.3389/fimmu.2025.1590951

479 views

ORIGINAL RESEARCH

Published on 09 Jun 2025

TMEM115: a promising marker for glioma immunotherapy and prognosis

Hang Yin
Feng Wang
Haiyan Xu
Manyu Xu
Pengpeng Lu
Xiaojing Zhang
Lei Yang
Bing Lu
Pingping Sun
Jianfei Huang

doi 10.3389/fimmu.2025.1598499

564 views

MINI REVIEW

Published on 02 Jun 2025

Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations

Xinyu Li
Hui Qiu
Qiuji Wu

doi 10.3389/fimmu.2025.1601572

333 views

ORIGINAL RESEARCH

Published on 13 May 2025

MYB Proto-Oncogene Like 2 identified as a biomarker for uterine corpus endometrial carcinoma: evidence from bioinformatics and clinical validation

Jiaoyun Lu
Furong Luo

doi 10.3389/fonc.2025.1595485

643 views

ORIGINAL RESEARCH

Accepted on 07 May 2025

Identification of anoikis-related subtypes and a risk score prognosis model, the association with TME landscapes and therapeutic responses in hepatocellular carcinoma

Bin Jin
Xiangyu Zhai
Xinlu Zhang
Yanmei Wu
Huaxin Zhou
Hao Zhang
Chongzhong Liu
Zili Zhang

doi 10.3389/fimmu.2025.1602831

ORIGINAL RESEARCH

Published on 05 May 2025

TNFRSF12A expression in stomach adenocarcinoma and its preliminary role in predicting immunotherapy response

Lin-De Sun
Lin-Lin Zhang
Zheng Wan
Xiao-Dong Yang
Jing Yao
Ze-Long Yang
Lin Liu
Jun-Yan Liu

doi 10.3389/fimmu.2025.1578068

1,182 views

ORIGINAL RESEARCH

Published on 17 Apr 2025

The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients

Hao Zhang
Zirui Zhuang
Li Hong
Ruipeng Wang
Jinjing Xu
Youyuan Tang

doi 10.3389/fimmu.2025.1589678

1,231 views

ORIGINAL RESEARCH

Published on 16 Apr 2025

Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinoma

Kun Zhang
Huyang Xie
Fan Zhao
Yeqing Huang

doi 10.3389/fimmu.2025.1564784

1,075 views

MINI REVIEW

Published on 08 Apr 2025

The role of tumor-associated macrophages in HPV induced cervical cancer

Zeping Chen
Binzhu Zhao

doi 10.3389/fimmu.2025.1586806

1,797 views

MINI REVIEW

Published on 02 Apr 2025

Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances

Dong Xie
Yang Liu
Fangbiao Xu
Zhibo Dang
Mengge Li
Qinsheng Zhang
Zhongqin Dang

doi 10.3389/fimmu.2025.1581098

2,409 views

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Molecular and Cellular Oncology
- 3.5 impact factor
- 6.2 citescore

Impact

59kTopic views
39kArticle views
15kArticle downloads

View impact

Articles

Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed

Bioinformatics-based analysis of nicotinamide adenine dinucleotide metabolism genes to predict immune status and prognosis for head and neck squamous cell carcinoma patients

Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer

TMEM115: a promising marker for glioma immunotherapy and prognosis

Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations

MYB Proto-Oncogene Like 2 identified as a biomarker for uterine corpus endometrial carcinoma: evidence from bioinformatics and clinical validation

Identification of anoikis-related subtypes and a risk score prognosis model, the association with TME landscapes and therapeutic responses in hepatocellular carcinoma

TNFRSF12A expression in stomach adenocarcinoma and its preliminary role in predicting immunotherapy response

The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients

Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinoma

The role of tumor-associated macrophages in HPV induced cervical cancer

Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy

Molecular and Cellular Oncology